JP2011516417A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011516417A5 JP2011516417A5 JP2011501153A JP2011501153A JP2011516417A5 JP 2011516417 A5 JP2011516417 A5 JP 2011516417A5 JP 2011501153 A JP2011501153 A JP 2011501153A JP 2011501153 A JP2011501153 A JP 2011501153A JP 2011516417 A5 JP2011516417 A5 JP 2011516417A5
- Authority
- JP
- Japan
- Prior art keywords
- pain
- disease
- pharmaceutical composition
- composition according
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4008708P | 2008-03-27 | 2008-03-27 | |
| US61/040,087 | 2008-03-27 | ||
| PCT/EP2009/002241 WO2009118187A1 (en) | 2008-03-27 | 2009-03-26 | Methods for treating disorders using nmda nr2b-subtype selective antagonist |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014020051A Division JP2014098018A (ja) | 2008-03-27 | 2014-02-05 | Ｎｍｄａｎｒ２ｂ−サブタイプ選択的アンタゴニストを使用する障害の処置方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011516417A JP2011516417A (ja) | 2011-05-26 |
| JP2011516417A5 true JP2011516417A5 (https=) | 2012-01-05 |
Family
ID=40910288
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011501153A Pending JP2011516417A (ja) | 2008-03-27 | 2009-03-26 | Ｎｍｄａｎｒ２ｂ−サブタイプ選択的アンタゴニストを使用する障害の処置方法 |
| JP2014020051A Pending JP2014098018A (ja) | 2008-03-27 | 2014-02-05 | Ｎｍｄａｎｒ２ｂ−サブタイプ選択的アンタゴニストを使用する障害の処置方法 |
| JP2015236571A Pending JP2016094430A (ja) | 2008-03-27 | 2015-12-03 | Ｎｍｄａｎｒ２ｂ−サブタイプ選択的アンタゴニストを使用する障害の処置方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014020051A Pending JP2014098018A (ja) | 2008-03-27 | 2014-02-05 | Ｎｍｄａｎｒ２ｂ−サブタイプ選択的アンタゴニストを使用する障害の処置方法 |
| JP2015236571A Pending JP2016094430A (ja) | 2008-03-27 | 2015-12-03 | Ｎｍｄａｎｒ２ｂ−サブタイプ選択的アンタゴニストを使用する障害の処置方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20110053951A1 (https=) |
| EP (1) | EP2254580A1 (https=) |
| JP (3) | JP2011516417A (https=) |
| KR (1) | KR20100135847A (https=) |
| CN (1) | CN101977606A (https=) |
| AU (1) | AU2009228660B2 (https=) |
| BR (1) | BRPI0909378A2 (https=) |
| CA (1) | CA2719749A1 (https=) |
| IL (1) | IL207835A0 (https=) |
| MX (1) | MX2010009649A (https=) |
| NZ (1) | NZ588698A (https=) |
| RU (1) | RU2499598C2 (https=) |
| WO (1) | WO2009118187A1 (https=) |
| ZA (1) | ZA201006587B (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20140146217A (ko) | 2012-04-20 | 2014-12-24 | 유씨비 파마, 에스.에이. | 파킨슨병을 치료하는 방법 |
| US11232319B2 (en) | 2014-05-16 | 2022-01-25 | The Trustees Of The University Of Pennsylvania | Applications of automatic anatomy recognition in medical tomographic imagery based on fuzzy anatomy models |
| WO2016025917A1 (en) * | 2014-08-15 | 2016-02-18 | Janssen Pharmaceuticals, Inc. | Triazoles as nr2b receptor inhibitors |
| US10155727B2 (en) | 2014-08-15 | 2018-12-18 | Janssen Pharmaceuticals, Inc. | Pyrazoles |
| KR102613179B1 (ko) | 2015-06-01 | 2023-12-14 | 뤼겐 홀딩스 (케이맨) 리미티드 | Nr2b nmda 수용체 길항제로서의 3,3-디플루오로피페리딘 카바메이트 헤테로사이클릭 화합물 |
| AU2016291158B2 (en) | 2015-07-09 | 2020-04-30 | Janssen Pharmaceutica Nv | Substituted 4-azaindoles and their use as GluN2B receptor modulators |
| US10071988B2 (en) | 2016-02-10 | 2018-09-11 | Janssen Pharmaceutica Nv | Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators |
| US10487055B2 (en) | 2016-06-01 | 2019-11-26 | Rhode Island Board Of Education | Diindole compounds useful in treatment of nervous system disorders |
| TW201819376A (zh) | 2016-10-06 | 2018-06-01 | 比利時商健生藥品公司 | 經取代之１Ｈ－咪唑並［４，５－ｂ］吡啶－２（３Ｈ）－酮及其作為ＧＬＵＮ２Ｂ受體調節劑之用途 |
| US11000526B2 (en) | 2016-11-22 | 2021-05-11 | Rugen Holdings (Cayman) Limited | Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders |
| US10732235B2 (en) * | 2018-03-29 | 2020-08-04 | Siemens Healthcare Gmbh | Magnetic resonance method and apparatus using atlas-based masking for quantitative susceptibility mapping |
| WO2019193516A2 (en) | 2018-04-04 | 2019-10-10 | Janssen Pharmaceutica Nv | Substituted pyridine and pyrimidines and their use as glun2b receptor modulators |
| CA3143103A1 (en) | 2019-06-14 | 2020-12-17 | Janssen Pharmaceutica Nv | Pyridine carbamates and their use as glun2b receptor modulators |
| JP7667097B2 (ja) | 2019-06-14 | 2025-04-22 | ヤンセン ファーマシューティカ エヌ．ベー． | 置換ピラゾロ－ピリジンアミド及びｇｌｕｎ２ｂ受容体調節因子としてのその使用 |
| TW202112774A (zh) | 2019-06-14 | 2021-04-01 | 比利時商健生藥品公司 | 經取代之吡唑并－吡啶醯胺及其作為ｇｌｕｎ２ｂ受體調節劑之用途 |
| BR112021025141A2 (pt) | 2019-06-14 | 2022-01-25 | Janssen Pharmaceutica Nv | Pirazolo-piridinas heteroaromáticas substituídas e seu uso como moduladores do receptor glun2b |
| AU2020293642A1 (en) | 2019-06-14 | 2022-01-20 | Janssen Pharmaceutica Nv | Substituted pyrazolo[4,3-b]pyridines and their use as GluN2B receptor modulators |
| MX2021015511A (es) | 2019-06-14 | 2022-01-31 | Janssen Pharmaceutica Nv | Carbamatos de pirazina y sus usos como moduladores del receptor glun2b. |
| CN114008052A (zh) | 2019-06-14 | 2022-02-01 | 詹森药业有限公司 | 取代的吡唑并-吡嗪以及它们作为GluN2B受体调节剂的用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1131031C (zh) * | 1996-03-08 | 2003-12-17 | 弗·哈夫曼-拉罗切有限公司 | 作为nmda受体亚型阻断剂的4－苯基3，6－二氢－2h－吡啶基衍生物的应用 |
| US5985936A (en) * | 1997-12-18 | 1999-11-16 | Forbes Medi-Tech, Inc. | Method of preventing and delaying onset of Alzheimer's disease and composition therefor |
| US6015824A (en) * | 1998-02-10 | 2000-01-18 | Hoffmann-La Roche Ag | Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders |
| TWI254043B (en) * | 1999-06-08 | 2006-05-01 | Hoffmann La Roche | Ethanesulfonyl-piperidine derivatives having good affinity to N-methyl-D-aspartate (NMDA) receptor |
| ATE257827T1 (de) * | 1999-07-21 | 2004-01-15 | Hoffmann La Roche | Triazolderivate |
| ATE274494T1 (de) * | 2000-04-20 | 2004-09-15 | Hoffmann La Roche | Pyrrolidin und piperidin derivate für die behandlung von neurodegenerativen erkrankungen |
| US6432985B2 (en) * | 2000-04-25 | 2002-08-13 | Hoffmann-La Roche Inc. | Neuroprotective substituted piperidine compounds with activity as NMDA NR2B subtype selective antagonists |
| US7022882B2 (en) * | 2000-10-06 | 2006-04-04 | The Regents Of The University Of California | NMDA receptor channel blocker with neuroprotective activity |
| US7005432B2 (en) * | 2002-05-16 | 2006-02-28 | Hoffman-La Roche Inc. | Substituted imidazol-pyridazine derivatives |
| JP2009503520A (ja) * | 2005-07-29 | 2009-01-29 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | ベータアミロイド受容体及びその使用 |
-
2009
- 2009-03-26 MX MX2010009649A patent/MX2010009649A/es active IP Right Grant
- 2009-03-26 BR BRPI0909378A patent/BRPI0909378A2/pt not_active IP Right Cessation
- 2009-03-26 JP JP2011501153A patent/JP2011516417A/ja active Pending
- 2009-03-26 CA CA2719749A patent/CA2719749A1/en not_active Abandoned
- 2009-03-26 NZ NZ588698A patent/NZ588698A/en not_active IP Right Cessation
- 2009-03-26 CN CN2009801104274A patent/CN101977606A/zh active Pending
- 2009-03-26 US US12/919,804 patent/US20110053951A1/en not_active Abandoned
- 2009-03-26 WO PCT/EP2009/002241 patent/WO2009118187A1/en not_active Ceased
- 2009-03-26 EP EP09724248A patent/EP2254580A1/en not_active Withdrawn
- 2009-03-26 KR KR1020107023896A patent/KR20100135847A/ko not_active Ceased
- 2009-03-26 AU AU2009228660A patent/AU2009228660B2/en not_active Ceased
- 2009-03-26 RU RU2010143864/15A patent/RU2499598C2/ru not_active IP Right Cessation
-
2010
- 2010-08-26 IL IL207835A patent/IL207835A0/en unknown
- 2010-09-14 ZA ZA2010/06587A patent/ZA201006587B/en unknown
-
2014
- 2014-02-05 JP JP2014020051A patent/JP2014098018A/ja active Pending
-
2015
- 2015-12-03 JP JP2015236571A patent/JP2016094430A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011516417A5 (https=) | ||
| RU2010143864A (ru) | Способы лечения нарушений с применением селективного антагониста nr2b-подтипа nmda рецепторов | |
| JP2013525444A5 (https=) | ||
| US20240262840A1 (en) | Heterocyclic flavone derivatives, compositions, and methods related thereto | |
| JP2015501783A5 (https=) | ||
| NZ589445A (en) | Rasagiline for parkinson's disease modification | |
| CY1121781T1 (el) | Φαρμακοτεχνικες μορφες παρατεταμενης απελευθερωσης της ρασαγιλινης και χρησεις αυτων | |
| JP2013523733A5 (https=) | ||
| JP2013526544A5 (https=) | ||
| WO2012009258A3 (en) | Peptidomimetic galanin receptor modulators | |
| JP2010001302A5 (https=) | ||
| EA201000384A1 (ru) | Новая полиморфная форма ротиготина и способ её получения | |
| JP2013533287A5 (https=) | ||
| JP2012523395A5 (https=) | ||
| JP2011527333A5 (https=) | ||
| JP2015535290A5 (https=) | ||
| JP2011505356A5 (https=) | ||
| JP2019512469A5 (https=) | ||
| RU2009135016A (ru) | Твердые формы, содержащие (-)-о-десметилвенлафаксин, и их применения | |
| JP2013502446A5 (https=) | ||
| MX2011008627A (es) | Metodos de administracion de (4ar, 10ar)-1-n-propil-1,2,3,4,4a,5,1 0,10a-octahidro-benzo[g]quinolin-6,7-diol y compuestos relacionados a traves de la mucosa oral, la mucosa nasal o la piel y composiciones farmaceuticas de los mismos. | |
| JP2012531402A5 (https=) | ||
| TW201420133A (zh) | 針對嚴重頭痛之普拉克索的經皮遞送 | |
| JP2013536837A5 (https=) | ||
| JP2019218379A5 (https=) |